In today’s changing global pharmaceutical/ device business environment, outstanding team working is essential. Creating a unified global high-performing team is one of the most important factors for successful drug and device development. It is important to recognise the importance of team interactions and the need for the different global teams to be in alignment on productivity and quality and this important element of team performance can often be overlooked.
This interactive workshop will focus on how to align members of the team and the wider teams, particularly working in a matrix or in a global environment through various group discussions, stimulating exercises and case studies. The workshop will help enhance team working and team’s performance.
This course, designed specifically for the pharmaceutical, device and animal health industries, will be relevant for existing team leaders and managers who wish to develop their team to a higher level. It will also be beneficial for any team member to attend.
Developing your team leadership
Matrix team management
Effective team communication
Motivating the team
Planning project team activities
Supporting project team progress
Proactively identify issues and risks and how to manage these
CAPA (Corrective and Preventative Action) management and team problem solving to ensure appropriate quality
Providing feedback to team members
Dr Laura Brown MBA, BSc,PhD, is a Pharmaceutical QA and Training Consultant, Course Director for the MSc in Clinical Research, School of Pharmacy at the University of Cardiff. She has more than 20 years’ experience of quality assurance in the pharmaceutical industry and has worked for several companies, including GSKs Hoechst Marion Roussel, Farmitalia and Phoenix International. She has a particular expertise in quality assurance including risked based approaches to quality systems, data Integrity and project management in the pharmaceutical industry. She regularly writes on pharmaceutical regulatory issues including “The Planning of International Drug Development”, in the Clinical Research Manual, Euromed and the “Impact of Brexit”, RQA Journal 2017.